Cosmos Health Net Income
| COSM Stock | USD 0.38 0.01 2.70% |
As of the 17th of February 2026, Cosmos Health shows the Mean Deviation of 3.8, risk adjusted performance of (0.11), and Standard Deviation of 5.52. Cosmos Health technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm's future prices. Please confirm Cosmos Health market risk adjusted performance, information ratio, as well as the relationship between the Information Ratio and skewness to decide if Cosmos Health is priced correctly, providing market reflects its regular price of 0.38 per share. As Cosmos Health appears to be a penny stock we also recommend to validate its jensen alpha numbers.
Cosmos Health Total Revenue |
|
Gross Profit | Profit Margin | Market Capitalization | Enterprise Value Revenue 0.5744 | Revenue |
| Last Reported | Projected for Next Year | ||
| Net Loss | -14.6 M | -13.8 M | |
| Net Loss | -14.6 M | -13.8 M | |
| Net Loss | -14 M | -13.3 M | |
| Net Loss | (0.76) | (0.80) | |
| Net Income Per E B T | 0.95 | 0.70 |
Cosmos | Net Income | Build AI portfolio with Cosmos Stock |
Evaluating Cosmos Health's Net Income across multiple reporting periods reveals the company's ability to sustain growth and manage resources effectively. This longitudinal analysis highlights inflection points, cyclical patterns, and structural changes that short-term snapshots might miss, offering deeper insight into Cosmos Health's fundamental strength.
Latest Cosmos Health's Net Income Growth Pattern
Below is the plot of the Net Income of Cosmos Health over the last few years. Net income is one of the most important fundamental items in finance. It plays a large role in Cosmos Health financial statement analysis. It represents the amount of money remaining after all of Cosmos Health operating expenses, interest, taxes and preferred stock dividends have been deducted from a company total revenue. It is Cosmos Health's Net Loss historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Cosmos Health's overall financial position and show how it may be relating to other accounts over time.
| View | Last Reported (16.18 M) | 10 Years Trend |
|
Net Income |
| Timeline |
Cosmos Net Income Regression Statistics
| Arithmetic Mean | (6,108,201) | |
| Geometric Mean | 1,570,585 | |
| Coefficient Of Variation | (118.88) | |
| Mean Deviation | 6,106,284 | |
| Median | (6,209,768) | |
| Standard Deviation | 7,261,305 | |
| Sample Variance | 52.7T | |
| Range | 24.6M | |
| R-Value | (0.82) | |
| Mean Square Error | 18.6T | |
| R-Squared | 0.67 | |
| Significance | 0.00006 | |
| Slope | (1,176,549) | |
| Total Sum of Squares | 843.6T |
Cosmos Net Income History
Other Fundumenentals of Cosmos Health
| Net Income From Continuing Ops | ||
| Net Income Applicable To Common Shares | ||
| Net Income Per Share | ||
| Net Income Per E B T |
Cosmos Health Net Income component correlations
Cosmos Net Income Driver Correlations
Understanding the fundamental principles of building solid financial models for Cosmos Health is extremely important. It helps to project a fair market value of Cosmos Stock properly, considering its historical fundamentals such as Net Income. Since Cosmos Health's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Cosmos Health's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Cosmos Health's interrelated accounts and indicators.
Click cells to compare fundamentals
Will Health Care Providers & Services sector continue expanding? Could Cosmos diversify its offerings? Factors like these will boost the valuation of Cosmos Health. Projected growth potential of Cosmos fundamentally drives upward valuation adjustments. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every Cosmos Health data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
Earnings Share (0.77) | Revenue Per Share | Quarterly Revenue Growth 0.379 | Return On Assets | Return On Equity |
Investors evaluate Cosmos Health using market value (trading price) and book value (balance sheet equity), each telling a different story. Calculating Cosmos Health's intrinsic value - the estimated true worth - helps identify when the stock trades at a discount or premium to fair value. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. External factors like market trends, sector rotation, and investor psychology can cause Cosmos Health's market price to deviate significantly from intrinsic value.
It's important to distinguish between Cosmos Health's intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding Cosmos Health should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. Conversely, Cosmos Health's market price signifies the transaction level at which participants voluntarily complete trades.
Cosmos Health 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Cosmos Health's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Cosmos Health.
| 11/19/2025 |
| 02/17/2026 |
If you would invest 0.00 in Cosmos Health on November 19, 2025 and sell it all today you would earn a total of 0.00 from holding Cosmos Health or generate 0.0% return on investment in Cosmos Health over 90 days. Cosmos Health is related to or competes with Femasys, Scynexis, Lisata Therapeutics, Nexgel, MetaVia, Passage Bio, and CASI Pharmaceuticals. Cosmos Holdings Inc. operates as a vertically integrated pharmaceutical company More
Cosmos Health Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Cosmos Health's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Cosmos Health upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | (0.16) | |||
| Maximum Drawdown | 29.76 | |||
| Value At Risk | (9.09) | |||
| Potential Upside | 8.16 |
Cosmos Health Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Cosmos Health's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Cosmos Health's standard deviation. In reality, there are many statistical measures that can use Cosmos Health historical prices to predict the future Cosmos Health's volatility.| Risk Adjusted Performance | (0.11) | |||
| Jensen Alpha | (0.95) | |||
| Total Risk Alpha | (1.26) | |||
| Treynor Ratio | (0.53) |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Cosmos Health's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Cosmos Health February 17, 2026 Technical Indicators
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | (0.11) | |||
| Market Risk Adjusted Performance | (0.52) | |||
| Mean Deviation | 3.8 | |||
| Coefficient Of Variation | (657.31) | |||
| Standard Deviation | 5.52 | |||
| Variance | 30.42 | |||
| Information Ratio | (0.16) | |||
| Jensen Alpha | (0.95) | |||
| Total Risk Alpha | (1.26) | |||
| Treynor Ratio | (0.53) | |||
| Maximum Drawdown | 29.76 | |||
| Value At Risk | (9.09) | |||
| Potential Upside | 8.16 | |||
| Skewness | 1.31 | |||
| Kurtosis | 4.49 |
Cosmos Health Backtested Returns
Cosmos Health secures Sharpe Ratio (or Efficiency) of -0.13, which signifies that the company had a -0.13 % return per unit of risk over the last 3 months. Cosmos Health exposes twenty-three different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please confirm Cosmos Health's Standard Deviation of 5.52, risk adjusted performance of (0.11), and Mean Deviation of 3.8 to double-check the risk estimate we provide. The firm shows a Beta (market volatility) of 1.6, which signifies a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Cosmos Health will likely underperform. At this point, Cosmos Health has a negative expected return of -0.73%. Please make sure to confirm Cosmos Health's treynor ratio, kurtosis, as well as the relationship between the Kurtosis and day typical price , to decide if Cosmos Health performance from the past will be repeated at some point in the near future.
Auto-correlation | 0.29 |
Poor predictability
Cosmos Health has poor predictability. Overlapping area represents the amount of predictability between Cosmos Health time series from 19th of November 2025 to 3rd of January 2026 and 3rd of January 2026 to 17th of February 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Cosmos Health price movement. The serial correlation of 0.29 indicates that nearly 29.0% of current Cosmos Health price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.29 | |
| Spearman Rank Test | 0.45 | |
| Residual Average | 0.0 | |
| Price Variance | 0.0 |
Because income is reported on the Income Statement of a company and is measured in dollars some investors prefer to use Profit Margin, which measures income as a percentage of sales.
| Competition |
Cosmos Accumulated Other Comprehensive Income
Accumulated Other Comprehensive Income |
|
Based on the recorded statements, Cosmos Health reported net income of (16.18 Million). This is 104.74% lower than that of the Health Care Providers & Services sector and significantly lower than that of the Health Care industry. The net income for all United States stocks is 102.83% higher than that of the company.
Cosmos Net Income Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Cosmos Health's direct or indirect competition against its Net Income to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Cosmos Health could also be used in its relative valuation, which is a method of valuing Cosmos Health by comparing valuation metrics of similar companies.Cosmos Health is currently under evaluation in net income category among its peers.
Cosmos Health Current Valuation Drivers
We derive many important indicators used in calculating different scores of Cosmos Health from analyzing Cosmos Health's financial statements. These drivers represent accounts that assess Cosmos Health's ability to generate profits relative to its revenue, operating costs, and shareholders' equity. Below are some of Cosmos Health's important valuation drivers and their relationship over time.
| 2021 | 2022 | 2023 | 2024 | 2025 | 2026 (projected) | ||
| Market Cap | 2.2M | 8.8M | 16.9M | 12.8M | 11.5M | 12.1M | |
| Enterprise Value | 29.1M | 67.8K | 25.5M | 24.3M | 21.9M | 23.0M |
Cosmos Health Institutional Holders
Institutional Holdings refers to the ownership stake in Cosmos Health that is held by large financial organizations, pension funds or endowments. Institutions may hold large blocks of Cosmos Health's outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing Cosmos Health's value.| Shares | Group One Trading, Lp | 2025-06-30 | 4.3 K | Tower Research Capital Llc | 2025-06-30 | 3.7 K | Advisor Group Holdings, Inc. | 2025-06-30 | 2.8 K | Citigroup Inc | 2025-06-30 | 2.7 K | Bank Of America Corp | 2025-06-30 | 205 | Simplex Trading, Llc | 2025-06-30 | 180 | Sbi Securities Co Ltd | 2025-06-30 | 112 | Susquehanna International Group, Llp | 2025-03-31 | 0.0 | Foundations Investment Advisors, Llc | 2025-06-30 | 0.0 | Blackrock Inc | 2025-06-30 | 267.8 K | Geode Capital Management, Llc | 2025-06-30 | 191.6 K |
Cosmos Fundamentals
| Return On Equity | -0.64 | ||||
| Return On Asset | -0.13 | ||||
| Profit Margin | (0.31) % | ||||
| Operating Margin | (0.11) % | ||||
| Current Valuation | 34.34 M | ||||
| Shares Outstanding | 37.35 M | ||||
| Shares Owned By Insiders | 27.10 % | ||||
| Shares Owned By Institutions | 8.01 % | ||||
| Number Of Shares Shorted | 105.79 K | ||||
| Price To Earning | 2.41 X | ||||
| Price To Book | 0.61 X | ||||
| Price To Sales | 0.24 X | ||||
| Revenue | 54.43 M | ||||
| Gross Profit | 6.82 M | ||||
| EBITDA | (13.92 M) | ||||
| Net Income | (16.18 M) | ||||
| Cash And Equivalents | 322.37 K | ||||
| Total Debt | 11.82 M | ||||
| Debt To Equity | 4.79 % | ||||
| Current Ratio | 1.05 X | ||||
| Book Value Per Share | 0.73 X | ||||
| Cash Flow From Operations | (7.72 M) | ||||
| Short Ratio | 0.23 X | ||||
| Earnings Per Share | (0.77) X | ||||
| Target Price | 4.5 | ||||
| Number Of Employees | 149 | ||||
| Beta | 4.47 | ||||
| Market Capitalization | 16.65 M | ||||
| Total Asset | 54.31 M | ||||
| Retained Earnings | (114.02 M) | ||||
| Working Capital | (296.19 K) | ||||
| Current Asset | 6.37 M | ||||
| Current Liabilities | 1.61 M | ||||
| Net Asset | 54.31 M |
About Cosmos Health Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Cosmos Health's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Cosmos Health using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Cosmos Health based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Prophet is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ProphetCheck out To learn how to invest in Cosmos Stock, please use our How to Invest in Cosmos Health guide.You can also try the Insider Screener module to find insiders across different sectors to evaluate their impact on performance.
Will Health Care Providers & Services sector continue expanding? Could Cosmos diversify its offerings? Factors like these will boost the valuation of Cosmos Health. Projected growth potential of Cosmos fundamentally drives upward valuation adjustments. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every Cosmos Health data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
Earnings Share (0.77) | Revenue Per Share | Quarterly Revenue Growth 0.379 | Return On Assets | Return On Equity |
Investors evaluate Cosmos Health using market value (trading price) and book value (balance sheet equity), each telling a different story. Calculating Cosmos Health's intrinsic value - the estimated true worth - helps identify when the stock trades at a discount or premium to fair value. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. External factors like market trends, sector rotation, and investor psychology can cause Cosmos Health's market price to deviate significantly from intrinsic value.
It's important to distinguish between Cosmos Health's intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding Cosmos Health should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. Conversely, Cosmos Health's market price signifies the transaction level at which participants voluntarily complete trades.